Printer Friendly

COMPANY INFORMATION
Neptune Technologies & Bioressources inc. 200-225 Promenade du Centropolis Laval, QC H7T 3B3 Tel: (450) 687-2262 Toll-free: (888) 664-9166 Fax: (450) 687-2272 Contact Name Toni Rinow Industry Pharmaceuticals		Key Executives Henri Harland, CEO André Godin, v-p, fin. & admin. Formulates and produces science-based and clinically proven phospholipid products for the nutraceutical and pharmaceutical markets.
FP ADVISOR COVERAGE Neptune Technologies & Bioressources inc. • FP Corporate Analyzer • FP Corporate Surveys • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/NTB Nasdaq/NEPT $2.09 $2.93 $0.61 n.a. n.a. n.a. 1.27 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 37,469 n.a. n.a. Aug. 31/09 143.02% -26.34% 47.44% $79,895
ANNUAL FINANCIALS Periods ended: 9m Feb. 28/09 12m May 31/08 12m May 31/07 $000s $000s $000s Operating revenue 8,589 10,264 8,126 Net income (1,889) (4,785) (2,677) Total assets 18,301 14,357 13,636 $ $ $ Earnings per share* (0.05) (0.13) (0.07) % % % Return on equity ... (60.55) (50.29)   * Common
TRAILING 12-MONTH VALUES Periods ended: Aug. 31/09 Aug. 31/08 $000s $000s Operating revenue 10,472 10,544 Net income (4,809) (4,332) $ $ Earnings per share (0.13) (0.12)

COMPANY NEWS

Results for 'Neptune Technologies & Bioressources inc.' from past 30 days: No hits. (Links are to articles.)